Related Interviews

Looking at a Company’s Fundamentals from a Long-Term Perspective
June 01, 2018
Goetz, John P.

Investing in Biotech Companies with Free Cash Flow and a Research Focus
December 28, 2017
Auxier, J. Jeffrey

Balancing Credit Risk and Duration Risk with Higher-Quality Bonds
June 30, 2017
Duffy, Peter

Biotech Space Lining Up for New Product Cycle
April 21, 2017
Singh, Hartaj

Looking for Change in the Large-Cap Universe
December 30, 2016
Crawford, Kenneth, James, Meghan

Finding Growth at a Reasonable Price in the Health Care Sector
December 30, 2016
Arens, Matt

Focusing on the Power of Compounding
November 04, 2016
Auxier, J. Jeffrey

Finding Above-Average Growth in Earnings Cycle Stocks
September 09, 2016
John, Shayne M.

Identifying Investments with an Opportunity for Value Creation
August 26, 2016
Lang, Daniel

Critical Demand for Innovation in Pharma and Biotech
August 12, 2016
Brozak, Steve

Tackling Specialty Pharma Headwinds by Focusing on Names with Organic Growth and Modest Leverage
August 12, 2016
Walewicz, Joseph

Looking for Biopharmaceuticals with Disruptive Innovation and Medicines Initiatives
August 12, 2016
Amusa, Gbola

A Diversified Yet Focused Long-Term Investment Portfolio
July 15, 2016
Dowling, John

Seeking Dependable Business Models and Capable Management Teams
April 08, 2016
Finkelstein, Michael P.

Using a Thematic Approach to Growth Investing
October 23, 2015
Kenneth D. Malamed

Managing Concentrated Portfolios of the Highest-Quality Businesses
December 22, 2014

Clinical Advancements and Drug Launches in Therapeutics Fuel Investor Enthusiasm
August 19, 2014

A Focus on Franchise Quality in Equity Selection
June 12, 2013

Alternative Dosage Forms Create Barriers Against Competition in Generics
March 26, 2013

July 11, 2006